The Harte Group

The Harte Group is a private clinical research and drug development services company focused on supporting pharmaceutical and biotechnology sponsors. The company operates as a virtual CRO and functional service provider, offering vendor oversight, clinical operations team support, patient recruitment, site management, biostatistics, and contract and budget negotiation support. Its positioning is to act as a bridge between drug sponsors and outsourced vendors/CROs in order to improve trial execution, timelines, and cost efficiency. The company appears to provide service-based support across Phase I through Phase IV studies rather than developing its own therapeutic pipeline. It is headquartered in Doylestown, Pennsylvania and was founded in 2008 or 2009 according to public sources.